Bangkok Genomics Innovation PCL (BKK:BKGI)
Thailand flag Thailand · Delayed Price · Currency is THB
1.300
-0.010 (-0.76%)
Mar 19, 2026, 11:18 AM ICT

BKK:BKGI Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
379.51337.59245.39304.77
Revenue Growth (YoY)
12.42%37.57%-19.48%-
Cost of Revenue
223.88197.52129.29147.26
Gross Profit
155.63140.08116.1157.52
Selling, General & Admin
111.3694.585.2293.97
Other Operating Expenses
-7.22-8.27-1.95-15.29
Operating Expenses
106.0187.6182.5277.78
Operating Income
49.6252.4633.5879.73
Interest Expense
-1.44-1.36-1.64-1.07
Earnings From Equity Investments
-0.32-0.08--
Pretax Income
47.8551.0231.9478.66
Income Tax Expense
2.520.86-0.23.54
Earnings From Continuing Operations
45.3350.1632.1475.11
Minority Interest in Earnings
0.020.01--
Net Income
45.3550.1732.1475.11
Net Income to Common
45.3550.1732.1475.11
Net Income Growth
-9.61%56.09%-57.21%-
Shares Outstanding (Basic)
600567440214
Shares Outstanding (Diluted)
600567440214
Shares Change (YoY)
5.78%28.91%105.72%-
EPS (Basic)
0.080.090.070.35
EPS (Diluted)
0.080.090.070.35
EPS Growth
-14.55%21.09%-79.20%-
Free Cash Flow
-107.41-23.4667.0353.9
Free Cash Flow Per Share
-0.18-0.040.150.25
Dividend Per Share
0.0500.0500.0544.666
Dividend Growth
--8.26%-98.83%-
Gross Margin
41.01%41.49%47.31%51.68%
Operating Margin
13.07%15.54%13.69%26.16%
Profit Margin
11.95%14.86%13.10%24.64%
Free Cash Flow Margin
-28.30%-6.95%27.31%17.68%
EBITDA
65.5864.8344.1688.82
EBITDA Margin
17.28%19.20%18.00%29.14%
D&A For EBITDA
15.9612.3710.579.08
EBIT
49.6252.4633.5879.73
EBIT Margin
13.07%15.54%13.69%26.16%
Effective Tax Rate
5.27%1.69%-4.51%
Revenue as Reported
379.51337.59245.39304.77
Source: S&P Global Market Intelligence. Standard template. Financial Sources.